ClinVar Miner

Submissions for variant NM_001182.5(ALDH7A1):c.76_82del (p.Ala26fs)

dbSNP: rs1373022366
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV002034850 SCV002107330 likely pathogenic not provided 2024-09-03 criteria provided, single submitter clinical testing Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV002266037 SCV002548159 likely pathogenic Pyridoxine-dependent epilepsy 2022-05-19 criteria provided, single submitter clinical testing Variant summary: ALDH7A1 c.76_82delGCCGCCT (p.Ala26SerfsX15) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory and observed in the HGMD database. The variant was absent in 201224 control chromosomes in version 2 of the gnomAD database and was filtered for not being a high quality genotype (annotated as AC0 for allele count 0). The variant is however reported as having passed quality filters in version 3 of the gnomAD database at a frequency of 0.000006569 in 152220 chromosomes. To our knowledge, no occurrence of c.76_82delGCCGCCT in individuals affected with Pyridoxine-Dependent Epilepsy and no experimental evidence demonstrating its impact on protein function have been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as uncertain significance. Based on the evidence outlined above, due to the rarity of this variant and a presumed true positive genotype ascertained in gnomAD v3.0, the variant was classified as likely pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.